Related Experiment Video
Updated: Jan 21, 2026

ATAC-Seq Optimization for Cancer Epigenetics Research
Published on: June 30, 2022
Optimizing symptom control in children and adolescents with cancer
L Lee Dupuis1,2,3, Sadie Cook1, Paula D Robinson4
1Program in Child Health Evaluative Sciences, The Hospital for Sick Children, Peter Gilgan Centre for Research and Learning, Toronto, ON, Canada.
Insights
Pediatric cancer patients frequently experience severe symptoms due to communication barriers and a lack of clinical practice guidelines (CPGs). Improving symptom management requires systematic screening, guideline development, and electronic health record integration.
Area of Science:
- Pediatric Oncology
- Symptom Management
- Cancer Treatment Side Effects
Background:
- A significant majority of pediatric oncology patients experience bothersome symptoms during cancer treatment.
- Poor symptom control stems from communication challenges, limited clinical practice guidelines (CPGs), and underutilization of effective interventions.
Purpose of the Study:
- To review current approaches for enhancing symptom control in children undergoing cancer therapy.
- To highlight the importance of systematic symptom screening and the development of CPGs.
Main Methods:
- Review of existing literature and approaches for symptom management in pediatric oncology.
- Discussion of challenges related to electronic health record integration and multi-symptom assessment scales.
Main Results:
- While multi-symptom assessment scales exist, their direct impact on patient management is limited.
- The number of CPGs for pediatric oncology symptom control is growing but remains insufficient.
Conclusions:
- Improving the creation and adherence to CPGs is a critical priority for pediatric cancer symptom management.
- Integrating symptom management systems into clinical workflows, particularly via electronic health records, is essential.
Abstract:
There is growing recognition of the degree to which symptoms negatively impact on children receiving cancer treatments. A recent study described that almost all inpatient pediatric oncology patients are experiencing at least one bothersome symptom and almost 60% are experiencing at least one severely bothersome symptom. Poor symptom control occurs because of challenges with communication of bothersome symptoms to clinicians, lack of clinical practice guidelines (CPGs) for most of these symptoms, and failure to administer preventative and therapeutic interventions known to be effective for symptom control. This article reviews approaches used to improve symptom control for children receiving cancer treatments. Areas addressed include systematic symptom screening and creation of CPGs for symptom management. Challenges with electronic health integration are also addressed. Several multi-symptom assessment scales have been developed but none have yet been used to directly influence patient management. The number of CPGs applicable to symptom control in pediatric oncology is increasing but remains small. Improving the creation of and adherence to CPGs for symptom management is an important priority. Finally, identifying ways that symptom management systems can be integrated into clinical work flows is essential; these will likely need to focus on electronic health records.
Related Concept Videos
Cognitive Development During Adolescence
Diabetes: Symptoms, Diagnosis, and Complications
Negative and Cognitive Symptoms of Schizophrenia
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
Asthma-III: Symptoms and Complications
Classification of Asthma
Pleural Effusion II: Symptoms and Management
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
Revisionist Views of Adolescent and Adult Cognition

